Science & Enterprise subscription

Follow us on Twitter

  • A solid majority of Americans express at least some doubts about biometrics for accessing computers, this weekend's… https://t.co/oUU1W1bX6E
    about 16 hours ago
  • New post on Science and Enterprise: Infographic – Americans Leery of Biometrics https://t.co/5xslb7xRX1 #Science #Business
    about 16 hours ago
  • Thanks @innerarchitect ... A local Arlington pub, but still beer. Enjoy the weekend. https://t.co/CpxP0ewUVC
    about 18 hours ago
  • An electronic wearable device worn as a patch is designed to act like a personal heating or cooling system in uncom… https://t.co/wTYoZ3MZD8
    about 1 day ago
  • New post on Science and Enterprise: Wearable Patch Designed for Personal Warmth, Cooling https://t.co/dvEVKGfKat #Science #Business
    about 1 day ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Recap – Editas Medicine Advances Crispr Therapy

Crispr genome edits illustration

(NIH.gov)

2 Dec. 2018. While much the world watched, and disapproved of, a Chinese researcher editing the genomes of embryos leading to the birth of twins, Editas Medicine in Cambridge, Massachusetts received the go-ahead to conduct a clinical trial using the genome editing technique Crispr. On Friday, the Food and Drug Administration, in an approved investigational new drug application, authorized Editas to test Crispr as a treatment for a rare inherited eye disease known as Leber congenital amaurosis type 10.

Here’s what else we reported on last week:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.